Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form.
Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form.
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...
ASCO 2024: The Effect of New Data on Prostate Cancer Care Dr Sandy Srinivas reflects on her patients who may benefit from the results of the PSMAfore trial. Medscape, June 25, 2024 Novel Strategies in ...
Study links higher expression of the gene PROX1 to aggressive change in prostate tumor cells; FDA-approved class of drugs can disable PROX1 ANN ARBOR, Michigan — Researchers at the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results